Erratum to “Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis”

erratum and corrigendum

© The American Society of Gene & Cell Therapy

doi:10.1038/mt.2016.113

Corrigendum to “AAVR: A Multi-Serotype Receptor for AAV” Candace Summerford and R Jude Samulski Molecular Therapy (2016) 24: 663–666. doi:10.1038/mt.2016.49

The second author was omitted from the byline, which should have appeared as follows: Candace Summerford, Jarrod S Johnson and R Jude Samulski Dr Johnson’s affiliation is Aderem Lab, Center for Infectious Disease Research, Seattle, Washington, USA.

doi:10.1038/mt.2016.144

Erratum to “Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis” Zan Shen, Chen Yao, Zifeng Wang, Lu Yue, Zheping Fang, Hong Yao, Feng Lin, Hui Zhao, Yuan-Jue Sun, Xiu-wu Bian, Wenqi Jiang, Xiaomei Wang, Yi Li, Gang Lu, Wai Sang Poon, Hsiang-Fu Kung and Marie Chia-mi Lin Molecular Therapy (2016) 24: 1358–1368. doi:10.1038/mt.2016.56

An incorrect version of this article published online. The corrected version appears in this issue. The publisher regrets the error.

1502

www.moleculartherapy.org  vol. 24 no. 8, 1502 aug. 2016